Barchart.com
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Trinity Bio ADR (TRIB)

Trinity Bio ADR (TRIB)
0.5500 x 2 0.5800 x 19
Post-market by (Cboe BZX)
0.5800 +0.0200 (+3.57%) 04/11/25 [NASDAQ]
0.5500 x 2 0.5800 x 19
Post-market 0.5800 unch (unch) 15:57 ET
News & Headlines for Fri, Apr 11th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 FinancialNewsMedia - Thu Jan 30, 8:00AM CST

EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END

TRIB : 0.5799 (+3.55%)
BIAF : 0.5424 (-3.16%)
INBS : 1.2700 (+4.10%)
CDIO : 0.4050 (+17.32%)
SOBR : 4.54 (-11.15%)
TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000% Stocktwits - Wed Jan 29, 8:04AM CST

“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.

TRIB : 0.5799 (+3.55%)
STSS : 0.0250 (+36.61%)
SLXN : 0.8450 (+2.55%)
Trinity Biotech plc Announces WHO Approval for Manufacturing Transfer of HIV Tests as Part of Comprehensive Transformation Plan Quiver Quantitative, Inc. - Wed Dec 18, 2024

Trinity Biotech updates on its transformation plan, announcing WHO approval for offshore HIV test manufacturing, enhancing growth potential.Quiver AI SummaryTrinity Biotech plc, a biotechnology company...

TRIB : 0.5799 (+3.55%)
Trinity Biotech plc Reports Q3 2024 Revenue Growth of 3% to $15.2 Million, Driven by Strong TrinScreen HIV Product Demand Quiver Quantitative, Inc. - Fri Nov 15, 2024

Trinity Biotech reported Q3 2024 revenue of $15.2 million, with a 3% year-over-year increase and strong Point-of-Care sales.Quiver AI SummaryTrinity Biotech plc reported a 3% year-on-year revenue growth...

TRIB : 0.5799 (+3.55%)
Trinity Biotech Announces Quarter 1 2022 Financial Results Globe Newswire - Thu Jun 30, 2022

DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 0.5799 (+3.55%)
Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results Globe Newswire - Wed Jun 29, 2022

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN...

TRIB : 0.5799 (+3.55%)
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test Globe Newswire - Fri May 20, 2022

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This...

TRIB : 0.5799 (+3.55%)
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea Globe Newswire - Tue May 3, 2022

DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the...

TRIB : 0.5799 (+3.55%)
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results Globe Newswire - Mon Apr 11, 2022

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 0.5799 (+3.55%)
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea Globe Newswire - Mon Apr 11, 2022

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the...

TRIB : 0.5799 (+3.55%)

Barchart Exclusives

This Nvidia-Backed AI Stock Is Shrugging Off Market Pain Thanks to the FDA. Should You Buy Shares Now? Barchart - 25 minutes ago
Recursion Pharmaceuticals stock rallied as FDA announces plans of using AI for drug testing. Is it too late to invest in RXRX shares? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
UTC
Reserve Your Spot